Ex utero Intrapartum Treatment to Resection of a Bronchogenic Cyst Causing Airway Compression

2014 ◽  
Vol 35 (2) ◽  
pp. 137-140 ◽  
Author(s):  
Debnath Chatterjee ◽  
Joy L. Hawkins ◽  
Stig Somme ◽  
Henry L. Galan ◽  
Jeremy D. Prager ◽  
...  
2015 ◽  
Vol 21 ◽  
pp. 6
Author(s):  
Roy Guinto ◽  
Michele Ledoux ◽  
Alicia Williams ◽  
Anthony Mark

Author(s):  
Je Yeon Lee ◽  
Jung Yup Lee ◽  
Sung Min Jin ◽  
Sang Hyuk Lee

2001 ◽  
Vol 44 (6) ◽  
pp. 707 ◽  
Author(s):  
Ji Seon Park ◽  
Dong Ho Lee ◽  
Joo Won Lim ◽  
Young Tae Ko ◽  
Sang Mok Lee ◽  
...  

Chirurgia ◽  
2019 ◽  
Vol 32 (3) ◽  
Author(s):  
Fabrizio Cremona ◽  
Antonio Sciuto ◽  
Dario P. Cassano ◽  
Paola Parente ◽  
Felice Pirozzi

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Jerzy Stanek

AbstractShort CommunicationsEXIT (ex-utero intrapartum treatment) procedure is a fetal survival-increasing modification of cesarean section. Previously we found an increase incidence of fetal vascular malperfusion (FVM) in placentas from EXIT procedures which indicates the underlying stasis of fetal blood flow in such cases. This retrospective analysis analyzes the impact of the recently introduced CD34 immunostain for the FVM diagnosis in placentas from EXIT procedures.Objectives and MethodsA total of 105 placentas from EXIT procedures (48 to airway, 43 to ECMO and 14 to resection) were studied. In 73 older cases, the placental histological diagnosis of segmental FVM was made on H&E stained placental sections only (segmental villous avascularity) (Group 1), while in 32 most recent cases, the CD34 component of a double E-cadherin/CD34 immunostain slides was also routinely used to detect the early FVM (endothelial fragmentation, villous hypovascularity) (Group 2). 23 clinical and 47 independent placental phenotypes were compared by χ2 or ANOVA, where appropriate.ResultsThere was no statistical significance between the groups in rates of segmental villous avascularity (29 vs. 34%), but performing CD34 immunostain resulted in adding and/or upgrading 12 more cases of segmental FVM in Group 2, thus increasing the sensitivity of placental examination for FVM by 37%. There were no other statistically significantly differences in clinical (except for congenital diaphragmatic hernias statistically significantly more common in Group 2, 34 vs 56%, p=0.03) and placental phenotypes, proving the otherwise comparability of the groups.ConclusionsThe use of CD34 immunostain increases the sensitivity of placental examination for FVM by 1/3, which may improve the neonatal management by revealing the increased likelihood of the potentially life-threatening neonatal complications.


2020 ◽  
Vol 52 ◽  
pp. 101337
Author(s):  
Adil Ayub ◽  
Abdul Majeed Abid ◽  
Sifrance Tran ◽  
Kanika Bowen-Jallow
Keyword(s):  

Head & Neck ◽  
2001 ◽  
Vol 23 (7) ◽  
pp. 590-593 ◽  
Author(s):  
Usamah M. Hadi ◽  
Hashem N. Jammal ◽  
Abdel Latif M. Hamdan ◽  
Ali M. Saad ◽  
Ghazi S. Zaatari
Keyword(s):  

1945 ◽  
Vol 32 (127) ◽  
pp. 357-364 ◽  
Author(s):  
N. Lloyd Rusby ◽  
T. Holmes Sellors

Sign in / Sign up

Export Citation Format

Share Document